GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OTCPK:HLBBF) » Definitions » FCF Margin %

H. Lundbeck AS (H. Lundbeck AS) FCF Margin % : 16.40% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. H. Lundbeck AS's Free Cash Flow for the three months ended in Mar. 2024 was $126 Mil. H. Lundbeck AS's Revenue for the three months ended in Mar. 2024 was $771 Mil. Therefore, H. Lundbeck AS's FCF Margin % for the quarter that ended in Mar. 2024 was 16.40%.

As of today, H. Lundbeck AS's current FCF Yield % is 11.32%.

The historical rank and industry rank for H. Lundbeck AS's FCF Margin % or its related term are showing as below:

HLBBF' s FCF Margin % Range Over the Past 10 Years
Min: -18.91   Med: 16.3   Max: 29.52
Current: 20.53

During the past 13 years, the highest FCF Margin % of H. Lundbeck AS was 29.52%. The lowest was -18.91%. And the median was 16.30%.

HLBBF's FCF Margin % is ranked better than
90.81% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.49 vs HLBBF: 20.53

H. Lundbeck AS FCF Margin % Historical Data

The historical data trend for H. Lundbeck AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS FCF Margin % Chart

H. Lundbeck AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.47 19.01 10.18 14.79 17.97

H. Lundbeck AS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.97 21.93 28.13 16.11 16.40

Competitive Comparison of H. Lundbeck AS's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

H. Lundbeck AS's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's FCF Margin % falls into.


H. Lundbeck AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

H. Lundbeck AS's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=523.644/2913.326
=17.97 %

H. Lundbeck AS's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=126.389/770.868
=16.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS FCF Margin % Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (H. Lundbeck AS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OTCPK:HLBBF) » Definitions » FCF Margin %
Comparable Companies
OCSE:STENO ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ SZSE:000538 BOM:500124 BOM:532321 TSE:4523 HKSE:03692 BOM:543904 NSE:DIVISLAB NSE:TORNTPHARM CTLT
Traded in Other Exchanges
HLUBF:USA 0ABR:UK 0ND5:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany
Address
Ottiliavej 9, Valby, DNK, 2500
Website
https://www.lundbeck.com
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.